glp-1 anti-obesity Drugs: What EM Physicians Need to Know Current Strategies in Managing Obesity

Mast cell activation and histamine intolerance overlap with oxalate sensitivity in a couple of ways: A study involving cell samples from patients with kidney stones found that they had higher mast cell counts than a healthy control group.[ref] Ketotifen, a drug that stops mast cell degranulation, reduces the formation of calcium oxalate kidney stones.[ref] Interestingly, the reason that stinging nettles cause severe skin irritation is that they contain oxalic acid and tartaric acid, which have been shown to activate mast cells.[ref][ref] Related article : Mast cell activation syndrome and Histamine intolerance Inflammation: Macrophage activation by oxalate crystals Macrophages are a type of white blood cell that can exist in an anti-inflammatory state (M2) that promotes healing or in a pro-inflammatory state (M1) that increases ROS and inflammation

April 25, 2025

Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by the Perelman School of Medicine at the University of Pennsylvania

Results do not immediately reverse when injections stop

Dose Optimization & Microdosing Instead of stopping suddenly, we reduce dosage in small, controlled increments

Does it work on a fully bald scalp